Dear Colleagues,
It is our distinct pleasure to invite you to participate in the Eleventh Middle East North Africa Committee for Treatment and Research in Multiple Sclerosis (MENACTRIMS) Congress, taking place on December 4–5, 2026, at the Intercontinental Dubai Festival City, with pre-congress activities scheduled for December 3, 2026.
As the region’s leading platform dedicated to multiple sclerosis (MS), the MENACTRIMS Congress continues to set the standard for excellence in education, research, and clinical advancement. Guided by an esteemed scientific committee, the 2026 edition will feature ground-breaking presentations delivered by internationally and regionally renowned experts.
Participants will gain comprehensive insights into the latest developments in MS treatments, clinical research, therapeutic strategies, pathology, imaging, epidemiology, diagnosis, biomarkers, neuromyelitis Optica spectrum disorders, and beyond.
Over two dynamic days, the congress will present major scientific updates through plenary sessions, high-level symposia, and interactive discussions. The program will also include dedicated parallel sessions for nurses, organized in collaboration with the International Organization of MS Nurses (IOMSN) and the Consortium of Multiple Sclerosis Centres (CMSC). In addition, the European Charcot Foundation will contribute a distinguished scientific symposium, further enriching the academic depth of the meeting.
With more than 1,000 healthcare professionals from across the globe expected to attend, the congress offers an exceptional opportunity to connect, collaborate, and exchange expertise with leaders committed to advancing MS care.
We look forward to welcoming you to Dubai — a vibrant, world-class destination — for what promises to be an inspiring and impactful congress experience.
Bassem I. Yamout
President
Raed Alroughani
Chair, Scientific Committee
Jihad Inshasi
Chair, Organizing Committee